竞争风险分析:骨科研究中的意义与应用时机
本文简述骨科生存分析中竞争风险的概念,指出当患者面临多个互斥事件(如死亡)或事件发生率相互依赖时,标准生存分析可能失效,并结合骨科实例说明适用情形。
要点
- 骨科生存分析常遇竞争风险,如死亡等互斥事件。
- 标准生存分析在竞争风险下可能产生偏倚。
- 需识别竞争风险情形并选用恰当分析方法。
核心结论
- 竞争风险在骨科生存分析中常见,标准生存分析在竞争风险下可能失效。
研究设计与样本
- 本文为方法学综述,简述生存分析删失方法、常见致命与非致命竞争事件,并结合骨科实例说明。
主要发现
- 竞争风险发生于患者面临多个互斥事件或事件率相互依赖时。
- 标准生存分析在竞争风险情形下可能失败。
临床怎么用
- 骨科研究分析时间-事件结局时,应识别竞争风险并考虑采用竞争风险分析方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most orthopedic studies involve survival analysis examining the time to an event of interest, such as a specific complication or revision surgery. Competing risks commonly arise in such studies when patients are at risk of more than one mutually exclusive event, such as death, or when the rate of an event depends on the rates of other competing events. In this article, we briefly describe the survival analysis censoring methodology, common fatal and nonfatal competing events, and define circumstances where standard survival analysis can fail in the setting of competing risks with real-world examples from orthopedics. Please visit the followinghttps://youtu.be/ifj_Mm3eGu8for a video that explains the highlights of the paper in practical terms.
引用
- Maradit Kremers H, Devick KL, Larson DR, et al. Competing Risk Analysis: What Does It Mean and When Do We Need It in Orthopedics Research? J Arthroplasty. 2021. PMID: 33934950. doi:10.1016/j.arth.2021.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。